Octane Medical acquires B. Braun’s global orthobiologics business
Search Symbol
Plus symbol to reveal more information.
Search Symbol
Plus symbol to reveal more information.

news

Progress happens everyday at Octane

Here’s what’s new

June 5, 2024

Octane Medical acquires B. Braun’s global orthobiologics business

Kingston, Ontario, Canada / Melsungen, Germany, June 5th, 2024 – Octane Medical Group, through its new venture Octane Biotherapeutics (BioTx), has acquired 100% shares of the global orthobiologics business from its long-term partner B. Braun. The acquisition, consisting of the two companies TETEC AG in Germany and Aesculap Biologics, LLC. in the United States, establishes Octane as an international leader in regenerative medicine. 

Read More

March 2, 2022

Octane HyperPEEK® offers breakthrough biocomposite for enhanced bone regeneration

Kingston, Ontario, June 2, 2022 – Octane Exo Inc., an Octane Medical Group venture, has achieved a breakthrough in medical implant technology with Octane HyperPEEK, an advanced biocomposite proven to enhance bone regeneration with the goal of enhanced integration and stability.

Read More

December 15, 2020

Octane Completes Major Expansion of State-of-the-Art Facility in Kingston, Ontario

Kingston, Ontario, 15 December 2020 – Octane Medical Group has expanded its state-of-the-art facility in Kingston, Ontario Canada. The 40,000-square-foot building, which Octane purchased in 2011, houses the company's head office and features regulated biolabs for biomaterial and biologics discovery programs including cell therapy research and development, a ...

Read More

March 18, 2020

Octane Wins 2020 Edison Award in Cellular Research for AUTOGRAFTA™ Synthesis of Living Grafts for Skeletal Reconstruction

Maine, USA, 18 March 2020 – Octane innovations in tissue engineering, personalized medicine and automated living implant production have earned one of the highest Edison Awards, winning Gold in the Medical / Dental Cellular Research category. The Gold award recognizes AUTOGRAFTA™ living graft technology and the ability to ...

Read More

October 29, 2018

Lonza Acquires a Controlling Stake in Octane Biotech to Further Develop Cocoon™ Autologous Technology

Basel, Switzerland, 29 October 2018 – Lonza announced today the acquisition of a controlling stake in Octane Biotech, with the right to acquire full ownership. The increase in equity share will allow Lonza to further develop the technology to support the growing need for scalable autologous manufacturing. Octane ...

Read More

March 9, 2018

Octane’s Cocoon Technology Wins Prestigious iF Design Award

Hannover, Germany, 09 March 2018 – iF International Forum Design GmbH has recognized Octane’s Cocoon technology with this year’s iF Design Award for best product – a tremendous honour from one of the world’s most celebrated and valued design competitions, with more than 6,000 submissions each year from ...

Read More

November 20, 2017

Cocoon Wins Silver in Spark Design Awards

New York, November 20, 2017 - Octane’s Cocoon automated bioreactor is this year’s recipient of the Silver prize in the Health category of the Spark Design Awards, an 11-year-old competition that recognizes modern designs which innovate, change the game and, in some way, help humanity or the environment ...

Read More

June 23, 2015

Octane and Lonza Announce Exclusive Collaboration to Evaluate Groundbreaking Autologous Cell Therapy Technology

Basel, Switzerland, and Ontario, Canada, 23 June 2015 – Lonza Group Ltd. in Switzerland and Octane Biotech Inc. in Canada have agreed to enter into an exclusive technology evaluation of the Cocoon™ cell production platform for personalized cell therapy manufacturing with the goal of a global deployment of ...

Read More

October 10, 2014

Octane and Jubilant forge partnership to launch the most advanced radioisotope delivery system for PET imaging

Kingston, Ontario, October 2014 – Octane Medical Group has established a collaboration with Jubilant DraxImage Inc., a subsidiary of the multinational Jubilant Life Sciences in Uttar Pradesh, India, to develop and produce radioisotope patient infusion lines for RUBY-FILL, the most advanced Positron Emission Tomography (PET) delivery system for ...

Read More

March 12, 2012

Octane joins forces with Aesculap to advance living-tissue orthopedic implants into clinical use

Kingston, Ontario, May 2012 – Octane Medical Group has entered into a partnership with Aesculap Biologics, LLC, a subsidiary of the multinational Aesculap Inc., (a B. Braun company) one of the world’s largest orthopedic companies with a focus on innovative spine and orthopedic treatments. The partnership is an ...

Read More